Advertisement
Advertisement
BSX
Boston Scientific Corp.
51.83
USDSponsored
+0.14
+0.27%
Aug 14, 15:59 UTC -4
Closed
After-Market
52.32
+0.49
+0.95%
BSX Earnings Reports
Positive Surprise Ratio
BSX beat 34 of 42 last estimates.
81%
Next Report
Date of Next Report
Oct 20, 2026
Estimate for Q3 26 (Revenue/ EPS)
$5.30B
/$0.81
Implied change from Q2 26 (Revenue/ EPS)
-2.53%
/-5.81%
Implied change from Q3 25 (Revenue/ EPS)
+4.73%
/+8.00%
Boston Scientific Corp. earnings per share and revenue
On Jul 29, 2026, BSX reported earnings of 0.86 USD per share (EPS) for Q2 26, beating the estimate of 0.83 USD, resulting in a 2.94% surprise. Revenue reached 5.44 billion, compared to an expected 5.42 billion, with a 0.50% difference. The market reacted with a -0.04% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 21 analysts forecast an EPS of 0.81 USD, with revenue projected to reach 5.30 billion USD, implying an decrease of -5.81% EPS, and decrease of -2.53% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Lumexa Imaging Holdings, Inc. Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
$0.16
Actual
$0.20
Surprise
+24.07%
Omeros Corporation
Report Date
Aug 12, 2026 For Q2 26
Estimate
-$0.27
Actual
$0.02
Surprise
+107.31%
Brainsway Ltd. - ADR
Report Date
Aug 12, 2026 For Q2 26
Estimate
$0.15
Actual
$0.14
Surprise
-7.65%
Valneva SE - ADR
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.34
Surprise
-243.33%
Capricor Therapeutics Inc
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.60
Actual
-$0.70
Surprise
-16.32%
Organigram Global Inc. Common Shares
Report Date
Aug 11, 2026 For Q3 26
Estimate
$0.00
Actual
-$0.06
Surprise
-2,480.74%
Immucell Corp
Report Date
Aug 13, 2026 For Q2 26
Estimate
-Actual
$0.20
Surprise
-
Accendra Health, Inc.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.19
Surprise
-113.00%
FitLife Brands, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
$0.19
Actual
$0.20
Surprise
+0.55%
Veru Inc.
Report Date
Aug 10, 2026 For Q3 26
Estimate
-$0.32
Actual
-$0.30
Surprise
+8.09%
FAQ
What were Boston Scientific Corp.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Boston Scientific Corp. reported EPS of $0.86, beating estimates by 2.94%, and revenue of $5.44B, 0.5% above expectations.
How did the market react to Boston Scientific Corp.'s Q2 2026 earnings?
The stock price moved down -0.04%, changed from $46.06 before the earnings release to $46.04 the day after.
When is Boston Scientific Corp. expected to report next?
The next earning report is scheduled for Oct 20, 2026.
What are the forecasts for Boston Scientific Corp.'s next earnings report?
Based on 21
analysts, Boston Scientific Corp. is expected to report EPS of $0.81 and revenue of $5.30B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement